United States · Exchanges & live quotes · Nasdaq
Astellas, Immuneering Enter Pancreatic Cancer Trial Collaboration
Detailed summary
(RTTNews) - Japanese drugmaker Astellas Pharma Inc. (ALPMY) announced on Thursday that it has entered into a clinical trial collaboration and supply agreement with Immuneering…
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)
